Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 265Leukemia, Lymphocytic, Chronic, B-Cell 66Lymphoma, Large B-Cell, Diffuse 60Neoplasms, Plasma Cell 50Lymphoma, Follicular 45Lymphoma, Mantle-Cell 42Lymphoma 41Recurrence 38Lymphoma, B-Cell, Marginal Zone 31Leukemia 30Leukemia, Myeloid, Acute 27Lymphoma, B-Cell 19Lymphoma, Non-Hodgkin 17Myelodysplastic Syndromes 16Waldenstrom Macroglobulinemia 15Smoldering Multiple Myeloma 13Hodgkin Disease 13Lymphoma, T-Cell, Peripheral 12Neoplasms 11Lymphoma, T-Cell 9Prostatic Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, T-Cell, Cutaneous 8Immunoglobulin Light-chain Amyloidosis 8Burkitt Lymphoma 8Sezary Syndrome 7Neoplasm, Residual 7Mycosis Fungoides 7Lymphoma, Large-Cell, Anaplastic 7Leukemia, Plasma Cell 6

Interventions

Everolimus 3liposomal doxorubicin 2Sorafenib 2Panobinostat 2Injections 2toripalimab 1titanium silicide 1temsirolimus 1satraplatin 1pembrolizumab 1netrin-1 inhibitor NP137 1navoximod 1mogamulizumab 1ixabepilone 1fludarabine 1apatinib 1Vinorelbine 1S 1 (combination) 1Radiosurgery 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Linoleic Acids, Conjugated 1Leucovorin 1Lenalidomide 1Lapatinib 1Interferon-gamma 1Immune Checkpoint Inhibitors 1Hydroxyurea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Solid Tumors × Lenalidomide × Clear all
NCT01155505 2011-09-13

Lenalidomide and Paclitaxel in Advanced Solid Tumors

Southern Europe New Drug Organization

Phase 1 Unknown
28 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡